MappBio in the News

November 24, 2020
Passive Immunization with mAbs Against Aerosolized Ricin Toxin                                                                Mar 6, 2020

Researchers Develop Successful New Treatment Against the Deadly Junin Virus – A team of researchers has made a discovery that could lead to the development of treatment for a deadly virus spread by rodents.

MB66 FAQ – MB66 is a multipurpose prevention technology intended to block sexual transmission of genital herpes and HIV.  It is currently being evaluated for safety and efficacy by a consortium of investigators.

PBS NewsHour – How to grow an Ebola vaccine with a tobacco plant
November 23, 2015

ZMapp™ is Granted Orphan Medicinal Product Designation by the EMA
October 15, 2015

ZMapp™ is Granted Fast Track Status by the FDA
September 17, 2015

Monoclonal Antibody-based Filovirus Therapeutic Licensed to Leaf Biopharmaceutical
July 15, 2014

Washington Post – The best innovations of 2014: ZMapp, for offering clues to a potential cure for Ebola
December 22, 2014

Status Update on ZMapp™
October 10, 2014

Consortium Wins Up to $28 Million from NIH to Find Best Proposed Ebola Treatment
March 20, 2014

International Joint Venture to Drive Commercialization of Filovirus Therapeutic via Monoclonal Antibodies
July 29, 2013

© 2017 Mapp Biopharmaceautical - Leaf Bio. All Rights Reserved.